+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG



Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG



Scandinavian Journal of Gastroenterology 51(12): 1502-1506



The hepatic venous pressure gradient (HVPG) could be used to stratify patients in different risk groups. No studies have reported the role of transjugular intrahepatic portosystemic shunt (TIPS) placement in a subgroup of patients with a high HVPG (≥20 mmHg) for secondary prophylaxis of variceal bleeding. This study was designed to evaluate the benefit of TIPS in cirrhotic patients with a high HVPG (≥20 mmHg) for rebleeding and survival. We included 46 cirrhotic patients with a history of variceal bleeding and a high HVPG (≥20 mmHg) admitted to our hospital between January 2013 and June 2014 (TIPS group). Patients were matched by Child-Pugh scores to patients in our historical cohort hospitalized for prophylaxis of variceal rebleeding between April 2011 and December 2012 (propranolol + EVL group). The end points included time to significant rebleeding from portal hypertensive sources, 1-year survival, and time to the occurrence of hepatic encephalopathy (HE). The 1-year actuarial probability of remaining free of variceal rebleeding was significantly higher in the TIPS group than in the propranolol + EVL group (85% vs. 54%, p = 0.01). The 1-year survival rates were not different between the two groups (85% vs. 89%, p = 0.591). The 1-year actuarial probability of remaining free of HE was significantly lower in the TIPS group than in the propranolol + EVL group (67% vs. 91%, p = 0.003). TIPS was more effective than propranolol + EVL in preventing variceal rebleeding in cirrhotic patients with a high HVPG (≥20 mmHg). During the limited follow-up, survival was similar in the two groups.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058816296

Download citation: RISBibTeXText

PMID: 27379704

DOI: 10.1080/00365521.2016.1193218


Related references

Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology 25(6): 1346-1350, 1997

Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Gastrointestinal Endoscopy 47(2): 202-204, 1998

Hvpg measurements to guide secondary prophylaxis for variceal bleeding a decision analysis. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1414, 2003

Endoscopic band ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices. Annals of Hepatology 9(1): 15-22, 2010

Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding. Liver International 31(1): 108-119, 2011

Primary prophylaxis of esophageal variceal bleeding in cirrhotic patients. Recenti Progressi in Medicina 99(12): 607-610, 2008

Primary prophylaxis of variceal bleeding in cirrhotic patients: a cohort study. Digestive and Liver Disease 40(12): 936-943, 2008

Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis. European Journal of Clinical Investigation 43(8): 844-854, 2013

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 62(11): 1634-1641, 2013

Prophylaxis of first variceal bleeding in cirrhotic patients by propranolol final report of a multicenter randomized study. Gastroenterologypart 2: 1717, 1986

Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding. Canadian Journal of Gastroenterology and Hepatology 2018: 3015891, 2018

Hemodynamic response to medical treatment as a predictive factor of efficacy of prophylaxis of the first variceal bleeding in cirrhotic patients. Hepatology 32(4 Pt 2): 517A, 2000

Review article the modern management of portal hypertension - primary and secondary prophylaxis of variceal bleeding in cirrhotic patients. Alimentary Pharmacology and Therapeutics 28(2): 178-186, 2008

Changes in transient elastography in early cirrhotic patients after receiving nonselective B-blocker for primary variceal bleeding prophylaxis: Three-month follow up. Jgh Open 2(5): 172-177, 2018

Prognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement. Disease Markers 31(3): 165-169, 2011